CG
APGN

Cutler Group’s Apexigen, Inc. Common Stock APGN Stock Holding History

Cutler Group’s Portfolio APGN Stock Details APGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-500
Closed -$2K – 4392
2023
Q1 		$2K Buy
+500
New +$602 ﹤0.01% 3305

Cutler Group's APGN Position: Q3 2023 in Review

Cutler Group sold out of Apexigen, Inc. Common Stock (APGN) in Q3 2023, closing a stake of 300 shares.

Cutler Group first reported a position in APGN in Q1 2023 and held it in 2 quarters. The position peaked at $0 in Q2 2023. 0 funds tracked by Wall St. Rank hold APGN as of Q3 2023.

  • Cutler Group reported no remaining Apexigen, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Cutler Group sold 300 Apexigen, Inc. Common Stock shares in Q3 2023.
  • Cutler Group first reported a position in Apexigen, Inc. Common Stock in Q1 2023 and held it in 2 quarters.
  • Cutler Group's Apexigen, Inc. Common Stock position peaked at $0 in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q3 2023.

Based on Cutler Group's 13F filing for Q3 2023, filed 7 Nov 2023.